Comparative 12-week effectiveness and safety outcomes of biologic agents ustekinumab, secukinumab and ixekizumab for the treatment of plaque psoriasis: a real-world multicenter retrospective study

J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e416-e418. doi: 10.1111/jdv.16366. Epub 2020 May 8.

J R Georgakopoulos¹, K Lam², V K Sandhu², A Ighani¹, M Phung³, V Piguet^{1

4}, J Yeung^{1

4

5

6}

¹ Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.
² Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
³ Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.
⁴ Division of Dermatology, Women's College Hospital, Toronto, ON, Canada.
⁵ Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
⁶ Probity Medical Research Inc., Waterloo, ON, Canada.

No abstract available

Publication types